Skip to content
ppharmaranks
Menu

Gadodiamide: uses, dosing, side effects & brands

Gadodiamide is a medicine sold in the U.S. under one brand. Below: what the FDA label says, every product that contains it, what the pills look like, and its recall record.

By the pharmaranks editorial teamReviewed against the FDA (openFDA label, NDC Directory & Enforcement) sourcesUpdated Jul 24, 2026How we research

Key facts

Available as
Injectable
Sold as
Omniscan
Prescription?
Prescription only
Generic available?
Not in our catalog

Every gadodiamide product we track (1)

Same active ingredient — different manufacturer, form, price and FDA recall record. That last one is what our independent score measures.

Only one: Omniscan.

Gadodiamide and breastfeeding

From LactMed, the US National Library of Medicine’s Drugs and Lactation Database — quoted, not rewritten.

Gadodiamide releases more free gadolinium than some other gadolinium-containing contrast agents and has been removed from the market in several countries. Some European guidelines recommend a 24-hour interruption of breastfeeding after a dose, but guidelines developed by several North American professional organizations state that breastfeeding need not be disrupted after a nursing mother receives a gadolinium-containing contrast medium. Other agents are preferred, especially while nursing a newborn or preterm infant.

Full LactMed record for gadodiamide: levels in milk, effects in breastfed infants, and the drugs it would consider instead

National Institute of Child Health and Human Development, record revised December 15, 2025. LactMed states its information is not a substitute for professional judgement.

What people report to the FDA about gadodiamide

The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 63 reports naming gadodiamide, and the FDA flagged 92% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:

  • nephrogenic systemic fibrosis22 reports
  • vomiting9 reports
  • skin hypertrophy6 reports
  • abdominal pain5 reports
  • emotional distress5 reports
  • nuclear magnetic resonance imaging brain abnormal5 reports
  • pruritus5 reports
  • confusional state4 reports

Read these as a signal, not a rate. A report does not mean gadodiamide caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label section above.

Source: openFDA drug/event (FAERS), retrieved July 25, 2026.

Related calculators

Frequently asked questions

Can you take gadodiamide with other medicines?

It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run gadodiamide against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.

What forms does gadodiamide come in?

Across the brands we track, gadodiamide is currently marketed as injectable, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.

Is there a generic gadodiamide?

We do not currently list a generic-labelled gadodiamide product. That does not always mean none exists — it means none appears under a generic name in the FDA data we track. Ask your pharmacist.

Cite this page
APA
pharmaranks. (2026, July 24). Gadodiamide: uses, dosing, side effects & brands. https://pharmaranks.com/drugs/gadodiamide
MLA
“Gadodiamide: uses, dosing, side effects & brands.” pharmaranks, 24 July 2026, https://pharmaranks.com/drugs/gadodiamide.

We summarise public FDA and NIH sources — for a clinical claim, cite the primary source we link to as well.

Sources: FDA openFDA drug label, National Drug Code Directory, and Enforcement (recall) database. This page reproduces public FDA data and is not medical advice. Dosing is set by your prescriber.

Read the full FDA label for gadodiamide on DailyMed (NIH) ↗.